Welcome to our dedicated page for Edgewell Pers Care Co SEC filings (Ticker: EPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Edgewell Personal Care Company filings document the financial reporting, governance and capital-structure disclosures of a Missouri-incorporated personal-care company whose common stock trades on the New York Stock Exchange under EPC. Current Reports on Form 8-K furnish quarterly and fiscal-year operating results, non-GAAP earnings materials and Regulation FD updates.
The filing record also covers completed asset-disposition disclosures for the sale of the Feminine Care segment and transition services arrangements related to that transaction. Proxy materials document annual meeting matters, director and executive compensation governance, shareholder voting items and approval of the amended and restated 2018 Stock Incentive Plan.
Dimensional Fund Advisors LP reports beneficial ownership of 2,615,057 shares of Edgewell Personal Care Co common stock, representing 5.6% of the class as of 12/31/2025. Dimensional has sole power to vote 2,544,917 of these shares and sole power to dispose of 2,615,057 shares.
The shares are owned by various investment funds and accounts advised or sub-advised by Dimensional and its subsidiaries, and Dimensional disclaims beneficial ownership, stating the securities are held for the Funds. The filing also certifies that the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Edgewell Personal Care.
Edgewell Personal Care Company is asking shareholders to vote at its 2026 Annual Meeting on four items: electing nine directors to one-year terms, ratifying PricewaterhouseCoopers LLP as independent auditor for fiscal 2026, approving executive pay on an advisory basis, and approving the 3rd Amended and Restated Stock Incentive Plan, which would add 2,100,000 shares to the equity pool.
Management highlights fiscal 2025 as a year of both challenge and transformation. The company chose to divest its Feminine Care business, targeting closing in the first calendar quarter of 2026, to focus on Shave, Sun and Skin Care, and Grooming. Edgewell returned $119.5 million to shareholders, including $90.2 million of share repurchases and $29.3 million of dividends. Sun and Skin Care net sales were $743.1 million, up 0.3%, and international markets delivered 3.5% organic growth.
For fiscal 2026, the company plans a transition year in North America while investing behind five focus brands and further productivity savings, aiming to stabilize the U.S. business and build toward growth in 2027 and beyond.
Edgewell Personal Care (EPC) CFO reports stock transactions. On 12/02/2025, the CFO exercised 2,296 restricted stock equivalents at an exercise price of $0, receiving 2,296 shares of EPC common stock. On the same date, 798 shares were withheld and disposed of at $17 per share to cover tax liabilities related to the vesting. After these transactions, the CFO directly beneficially owned 29,034 shares of EPC common stock, and 4,590 restricted stock equivalents remained beneficially owned.
Edgewell Personal Care Company (EPC) reported an insider stock transaction by its Chief Accounting Officer. The officer sold 333 shares of Edgewell Personal Care common stock on 11/20/2025 at a price of $17.21 per share, as shown in Table I of the filing. After this sale, the reporting person disclosed owning 0 shares of Edgewell Personal Care common stock directly.
Edgewell Personal Care Company (EPC) Chief Supply Chain Officer reported multiple equity award events. On November 13, 2025, 5,773 Performance Stock Equivalents (PSEs) converted into the same number of EPC common shares after performance conditions were met, while 10,580 PSEs were canceled for not meeting those conditions. Shares totaling 2,676 and 1,924 were withheld at $18.39 per share to cover tax liabilities on vesting. A separate award of 4,149 PSEs had its performance conditions satisfied on November 6, 2025 and time vesting completed on November 13, 2025. In addition, the officer received 15,445 Restricted Stock Equivalents (RSEs) on November 14, 2025, each convertible into one share of EPC common stock, vesting in three equal annual installments. Following these transactions, the officer beneficially owned about 48,564.693 shares of EPC common stock directly.
Edgewell Personal Care Company (EPC) is a Missouri-based global personal care manufacturer with operations in about 20 countries and product sales in more than 50 countries. It reports three main segments: Wet Shave (Schick, Wilkinson Sword, Billie and private label razors and shave prep), Sun and Skin Care (Banana Boat, Hawaiian Tropic, Bulldog, Jack Black, Cremo, Wet Ones) and Feminine Care (Playtex, Stayfree, Carefree, o.b.).
The company’s board approved an asset purchase agreement on November 6, 2025 to sell the entire Feminine Care segment for $340.0 million, subject to a purchase price adjustment at closing, which would materially reshape its portfolio toward shaving and skin care. Walmart accounted for approximately 17.4% of consolidated net sales in fiscal 2025, with Target also a significant customer in Sun and Skin Care and Feminine Care, highlighting customer concentration risk.
Edgewell outlines extensive risk factors including raw material and labor cost volatility, changing trade policies, intense competition from large global peers and private labels, heavy product and environmental regulation, litigation exposure and evolving sustainability expectations. The company employs about 6,700 people, emphasizes culture, safety and wellbeing, and pursues its Sustainable Care 2030 program focused on packaging, emissions, waste reduction and responsible sourcing.
Edgewell Personal Care (EPC) reported insider equity transactions by Chief Executive Officer and Director Rod R. Little. On 11/13/2025, 58,612 performance stock equivalents vested and converted into shares of common stock at an exercise price of $0. On the same date, 27,167 shares were withheld to cover tax liabilities at a price of $18.39 per share, leaving Little with 365,818 shares of common stock held directly.
In a related derivative transaction, the original performance award was 166,038 shares, of which only 58,612 vested based on performance criteria, with 107,426 shares cancelled. On 11/14/2025, Little received a grant of 103,420 restricted stock equivalents at an exercise price of $0. One-third of this award will vest and convert into Edgewell common stock on each of 11/14/2026, 11/14/2027, and 11/14/2028, subject to continued employment or certain other events.
Edgewell Personal Care Company (EPC) reported insider equity transactions by its Chief People & Legal Officer on 11/13/2025. A performance stock award vested, converting 5,773 performance stock equivalents into common shares at an exercise price of $0, increasing the officer’s direct holdings to 22,540 shares before related tax withholding. To cover tax liabilities on the vesting, 2,873 shares were withheld at a price of $18.39, leaving 19,667 common shares held directly afterward.
In a related equity grant dated 11/14/2025, the officer received 24,270 restricted stock equivalents at an exercise price of $0. These are scheduled to vest in three equal installments on 11/14/2026, 11/14/2027, and 11/14/2028, subject to continued employment, with potential accelerated vesting upon death, disability, change in control, or certain termination events. The original performance award was for 16,353 units, of which 10,580 were cancelled for not meeting performance criteria.
Edgewell Personal Care (EPC) reported insider equity activity by its CFO on a Form 4. On 11/13/2025, 2,754 performance stock equivalents were exercised at $0 and converted into common stock, while 958 shares were withheld at $18.39 to cover tax liabilities. Following these transactions, the CFO directly held 27,536 shares of common stock. In a related derivative transaction, the original performance award was 3,900 shares, of which 2,754 vested and 1,146 were cancelled based on performance criteria. On 11/14/2025, the CFO also received 26,476 restricted stock equivalents, scheduled to vest in three equal installments on 11/14/2026, 11/14/2027, and 11/14/2028, subject to continued employment or certain other events.
Edgewell Personal Care Company reported an equity award to one of its officers on Form 4. The reporting person, who serves as President, North America, received 26,476 restricted stock equivalents (RSEs) tied to Edgewell common stock on 11/14/2025 at an exercise price of $0.
According to the vesting terms, one-third of these RSEs will convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028, as long as the officer remains employed on those dates. All or a portion of the RSEs may vest earlier upon death, disability, a change in control, or certain termination events.